Skip to content

NNRTI-resistant HIV most frequently transmitted mutation in Spain, but overall prevalence low

Treatment interruption delivers no benefit for most heavily treated, despite resistance loss

Detectable viral loads in patients on antiretroviral therapy causes slow development of resistance

NNRTIs have a greater risk of resistance than PIs when used in regimens after treatment break

Superinfection with drug-resistant HIV: case reported

IAS: Use of crystal methamphetamine boosts risk of transmitting drug-resistant HIV

IAS: Virological failure rare in patients taking saquinavir / ritonavir

IAS: ‘Next generation’ NNRTI GW695634 is safe and active in NNRTI-resistant patients

IAS: Tipranavir combined with T-20 achieves good virologic results in the highly treatment experienced